Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities
Net income (loss)	$ 1,574	$ (11,714)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	4,917	3,949
Stock-based compensation	2,213	3,543
Provision for reserves on accounts receivable	(81)	67
Gain on sale of assets	(6,000)	0
Changes in assets and liabilities:
Accounts receivable	(1,800)	(14,713)
Prepaid expenses and other current assets	(898)	(986)
Other assets	465	314
Accounts payable	(3,878)	956
Accrued expenses	1,727	(3,999)
Operating leases	(130)	(81)
Deferred revenue	3,918	10,032
Net cash provided by (used in) operating activities	2,027	(12,632)
Investing activities
Proceeds from sale of assets	6,000	0
Purchases of property and equipment	(817)	(952)
Capitalized internal-use software costs	(2,182)	(3,930)
Net cash provided by (used in) investing activities	3,001	(4,882)
Financing activities
Deferred acquisition payments	0	(1,700)
Other financing activities	(239)	(225)
Net cash used in financing activities	(239)	(1,925)
Effect of exchange rate changes on cash and cash equivalents	(535)	23
Net increase (decrease) in cash and cash equivalents	4,254	(19,416)
Cash and cash equivalents at beginning of period	18,615	31,894
Cash and cash equivalents at end of period	22,869	12,478
Supplemental disclosure of cash flow information
Cash paid for operating lease liabilities	938	874
Cash paid for income taxes	$ 279	$ 505